Skip to main content

Zeldesmeran

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number2726459-47-6
Known Aliases (3)
Common Name
messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised version of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S) glycoprotein (based upon GenBank ID: MT270101.1), containing the D614G mutation, flanked by a 5' untranslated region (5'UTR) derived from the 5'UTR of tobacco etch virus and a 3' untranslated region (3'UTR) derived from the 3'UTR of Xenopus laevis beta globin mRNA, and terminated with a 3' polyadenylation (polyA) tail; contains N<sup>1</sup>-methylpseudouridine instead of uridine (all-U>m1Ψ) RNA (recombinant 5′-(m7G-(5′→5′)-ppp-Gm)-capped all uridine→N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 spike glycoprotein [614-glycine]-specifying plus 5′- and 3′-untranslated flanking region-containing poly(A)-tailed messenger PTX-COVID19-B), inner salt zeldesmeran [INN]
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) BD2KE88JH4 Zeldesmeran CAS: 2726459-47-6
INN: 12547
SMS_ID: 300000051847
FDA UNII: BD2KE88JH4
NCI_THESAURUS: C203100
Record Info
IDFXYvT3CnEy2RXCdmv8XKfG
CreatedApril 10, 2026, 10:41 p.m.
ModifiedApril 10, 2026, 11:04 p.m.
Data SourceFDA Substance Registry (openFDA)